RT Journal Article
SR Electronic
T1 The fading of the mpox outbreak among men who have sex with men: a mathematical modelling study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.31.23285294
DO 10.1101/2023.01.31.23285294
A1 Maria Xiridou
A1 Fuminari Miura
A1 Philippe Adam
A1 Eline Op de Coul
A1 John de Wit
A1 Jacco Wallinga
YR 2023
UL http://medrxiv.org/content/early/2023/02/01/2023.01.31.23285294.abstract
AB Background The mpox (monkeypox) outbreak in the Netherlands started winding down in July 2022, before the mpox vaccination programme was initiated. Most cases were men who have sex with men (MSM). We investigated whether the rapid decline in mpox could be attributed to depletion of susceptible MSM or to behavioural changes.Methods We developed a transmission model that was fitted to data on mpox cases in the Netherlands until 25 July 2022, when the mpox vaccination programme started. We included behavioural changes, namely less casual partners and shorter time until mpox cases abstain from sexual contacts.Results Without behavioural changes, the peak in modelled mpox cases matched observations, but the decline thereafter was less steep than observed. Allowing for behavioural changes in July 2022, we estimated a 13-24% decline in numbers of casual partners and halving of the infectious time until sexual abstinence. When the vaccination programme started, 64% of MSM with very high sexual activity in the model had been infected. Counterfactual model scenarios reveal that the outbreak could have waned by October 2022 even without the vaccination programme. Import of mpox cases at the end of 2022 could not result in major outbreaks.Conclusions The limited size of the mpox outbreak in the Netherlands can be ascribed to the depletion of susceptible MSM with high levels of sexual activity. The subsequent decline was accelerated by behavioural changes in July 2022. Immunity due to infection and vaccination among those most sexually active diminishes the risk of resurgence of mpox.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFuminari Miura received funding from Japan Society for the Promotion of Science (JSPS KAKENHI, Grant Number 20J00793). No other funding was received specific for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The source data on mpox cases were openly available when the study started. They can be freely and openly accessed on the website of the National Institute of Public Health and the Environment (RIVM) of the Netherlands: https://www.rivm.nl/en/mpox. All other data (used as input to inform model parameters; and data obtained as model output) are available upon reasonable request to the authorsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data for the numbers of daily mpox cases in the Netherlands described in this study can be freely and openly accessed on the website of the National Institute of Public Health and the Environment (RIVM) of the Netherlands: https://www.rivm.nl/en/mpox. All other data (used as input to inform model parameters; and data obtained as model output) are available upon reasonable request to the authors https://www.rivm.nl/en/mpox